Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery
Cancer stem cells (CSCs) are a small population of less differentiated cells with robust self-renewal ability. CSCs have been recognized as the root cause of tumor initiation, progression, relapse, and drug resistance. Recent studies from us and others have highlighted that N6-methyladenosine (m6A),...
Saved in:
Main Authors: | Honghai Zhang (Author), Xueer Wang (Author), Jianjun Chen (Author), Rui Su (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small molecule-based immunomodulators for cancer therapy
by: Yinrong Wu, et al.
Published: (2022) -
First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects
by: Rui Chen, et al.
Published: (2022) -
ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment
by: Zhenbo Han, et al.
Published: (2021) -
The Role of RNA Methylation in Regulating Stem Cell Fate and Function-Focus on m6A
by: Weiwei Sun, et al.
Published: (2021) -
Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
by: Li Liu, et al.
Published: (2024)